Molecular, endocrine, and genetic mechanisms of arterial calcification

被引:233
作者
Doherty, TM
Fitzpatrick, LA
Inoue, D
Qiao, JH
Fishbein, MC
Detrano, RC
Shah, PK
Rajavashisth, TB
机构
[1] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Burns & Allen Res Inst, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA
[4] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA
[5] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Div Endocrinol & Metab, Tokushima 7708503, Japan
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Harbor UCLA Res & Educ Inst, Dept Med, Div Cardiol, Torrance, CA 90512 USA
关键词
D O I
10.1210/er.2003-0015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pathologists have recognized arterial calcification for over a century. Recent years have witnessed a strong resurgence of interest in atherosclerotic plaque calcification because it: 1) can be easily detected noninvasively; 2) closely correlates with the amount of atherosclerotic plaque; 3) serves as a surrogate measure for atherosclerosis, allowing preclinical detection of the disease; and 4) is associated with heightened risk of adverse cardiovascular events. There are two major types of calcification in arteries: calcification of the media tunica layer (sometimes called Monckeberg's sclerosis), and calcification within subdomains of atherosclerotic plaque within the intimal layer of the artery. There are important similarities and differences between these two entities. Of particular interest are increasing parallels between cellular and molecular features of arterial calcification and bone biology, and this has led to accelerating interest in understanding how and why bone-like mineral deposits may form in arteries. Here, we review the two major pathological types of arterial calcification, the proposed models of calcification, and endocrine and genetic determinants that affect arterial calcification. In addition, we highlight areas requiring further investigation.
引用
收藏
页码:629 / 672
页数:44
相关论文
共 727 条
  • [1] Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754
  • [2] Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
    Adami, S
    Braga, V
    Guidi, G
    Gatti, D
    Gerardi, D
    Fracassi, E
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) : 599 - 604
  • [3] Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity
    Aguirre, J
    Buttery, L
    O'Shaughnessy, M
    Afzal, F
    de Marticorena, IF
    Hukkanen, M
    Huang, P
    MacIntyre, I
    Polak, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) : 247 - 257
  • [4] The transcrintion factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6
    Akiyama, H
    Chaboissier, MC
    Martin, JF
    Schedl, A
    de Crombrugghe, B
    [J]. GENES & DEVELOPMENT, 2002, 16 (21) : 2813 - 2828
  • [5] The debate concerning detection of coronary calcification: Who needs an electron beam computed tomography scan?
    Joseph S. Alpert
    [J]. Current Cardiology Reports, 2002, 4 (5) : 349 - 350
  • [6] *AM HEART ASS, 2003, HEART DIS STROK STAT
  • [7] Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
    Ammann, P
    Rizzoli, R
    Bonjour, JP
    Bourrin, S
    Meyer, JM
    Vassalli, P
    Garcia, I
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1699 - 1703
  • [8] Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
    An, JP
    Ribeiro, RCJ
    Webb, P
    Gustafsson, JÅ
    Kushner, PJ
    Baxter, JD
    Leitman, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15161 - 15166
  • [9] ANDERSON HC, 1989, LAB INVEST, V60, P320
  • [10] PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation
    Anderson, KL
    Smith, KA
    Perkin, H
    Hermanson, G
    Anderson, CG
    Jolly, DJ
    Maki, RA
    Torbett, BE
    [J]. BLOOD, 1999, 94 (07) : 2310 - 2318